ex-chem

Pfizer's Restructuring Still Leaves Employees in the Dark

Sounds almost identical to the "DPU" model being implemented at Glaxo. Hope for the research folk at Pfizer that the cuts are not as deep as at Glaxo (60-70%). I was one of the lucky ones-older, and well "packaged" for retirement!